It is generally believed that serious liver disease is rare…
This is wrong and harmful thinking for many people who are unaware of their disease.
In the European Union, 52 million people suffer from NAFLD/MAFLD at various stages of disease progression and levels of liver damage.
Rapid diagnosis and precise stratification of the degree of liver damage in the progressive process of fatty liver disease is the main challenge in the treatment of NAFLD/MAFLD.
2021 EASL Guidelines JHEP Reports 2021 vol. XXX: „Non-alcoholic fatty liver disease: A patient guideline” Medycyna Praktyczna, 20.03.2014 prof. Tomasz Mach – „Alkoholowe choroby wątroby” National Library of Medicine; LiverTox: Clinical and Research Information on Drug-Induced Liver Injury – Metotrexate 19.02.2020
Statistics on liver diseases in Poland
1.8 million patients abuse alcohol, of which 1.6 million suffer from alcoholic fatty liver disease
9.1 million obese patients, of which 8.2 million suffer from NAFLD/MAFLD
2.7 million patients with type II diabetes, including 1.75 million with NAFLD/MAFLD
0.9 million patients chronically use hepatotoxic drugs, including 0.14 million suffering from liver damage